Thyroid nodules are discrete lumps or growths that form within the thyroid gland. They are extremely common — detectable by ultrasound in up to 65% of the general population. The vast majority of thyroid nodules are benign (non-cancerous), but a small percentage require further evaluation to rule out malignancy.

How Are Thyroid Nodules Found?

Most thyroid nodules cause no symptoms and are discovered incidentally — during a neck examination, or when imaging (CT scan, MRI, ultrasound) is performed for another reason. Occasionally, a large nodule may cause:

  • A visible lump or swelling in the neck
  • Difficulty swallowing
  • A feeling of pressure in the throat
  • Hoarseness (if pressing on the voice box)
  • Neck pain (less commonly)

Evaluation of a Thyroid Nodule

When a nodule is found, the evaluation typically involves:

  • Blood tests: TSH to assess overall thyroid function. If TSH is low, a radionuclide scan may be done to determine if the nodule is "hot" (overactive) or "cold."
  • Thyroid ultrasound: The primary imaging tool. Ultrasound characterizes the nodule's size, composition (solid vs. cystic), echogenicity, and other features that help estimate the risk of malignancy.
  • Fine needle aspiration (FNA) biopsy: The gold standard for evaluating suspicious nodules. A thin needle is inserted into the nodule under ultrasound guidance to obtain cells for analysis.

📊 Thyroid Nodule Risk: Overall, only about 5–10% of thyroid nodules are cancerous. Ultrasound features and size guide the decision of whether biopsy is needed. Many small, low-risk nodules simply require periodic monitoring with repeat ultrasound.

The Bethesda System for Biopsy Results

FNA biopsy results are reported using the Bethesda system, which classifies cytology into six categories with associated malignancy risk:

CategoryDescriptionMalignancy Risk
INon-diagnostic1–4% (repeat biopsy needed)
IIBenign0–3%
IIIAtypia of undetermined significance6–18%
IVFollicular neoplasm10–40%
VSuspicious for malignancy45–75%
VIMalignant97–99%

Management

Management depends on the biopsy result and clinical context:

  • Benign nodules: Monitoring with repeat ultrasound at 1–2 year intervals is typically appropriate
  • Indeterminate nodules: Molecular testing (e.g., Afirma, ThyroSeq) can help refine the risk estimate and avoid unnecessary surgery in many cases
  • Suspicious or malignant nodules: Surgical referral for thyroidectomy

Key Takeaways

  • Thyroid nodules are very common — the vast majority are benign
  • Evaluation includes TSH blood test, thyroid ultrasound, and often fine needle aspiration biopsy
  • Only 5–10% of nodules turn out to be cancerous
  • Management ranges from monitoring to surgery depending on biopsy results
  • Molecular testing can help avoid unnecessary surgery for indeterminate results
Medical Disclaimer: This article is for educational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making any changes to your treatment plan. Individual medical decisions should be made in partnership with your physician based on your specific circumstances.